Abstract:Objective: To verify the safety, operability, and histocompatibility of the new implantable spinal cord stimulation (SCS) system. Methods: Three small-tailed Han sheep were performed the SCS system implantation under X-ray fluoroscopy-guided. The percutaneous leads, paddle leads, and implantable pulse generators (IPG) were placed. The postoperative animal behavioral changes and blood white blood cell (WBC) counts and impedance were observed. Spinal cord specimens were taken at one-month post-operation for hematoxylin-eosin (HE) staining, and the spinal cord structures of SCS stimulated and unstimulated segments were observed. Results: The postoperative movement and sensation of the sheep were healthy, the postoperative blood WBC counts fluctuated within the normal range, the intraoperative and postoperative impedance values were typical, and the system operation was regular. Compared with the unstimulated segment, the morphological structure of the spinal cord in the stimulated segment was reasonable, and no apparent cell necrosis, edema, ischemia, inflammation, and other pathological changes were observed. Conclusion: The new implantable SCS system has excellent biological safety and operability, which meets the needs of clinical application.